{"schema_version":"alpha-company-profile-public-v2","slug":"axogen-inc","canonical_url":"https://registry.alpha.ac/companies/axogen-inc","published_on":"2026-09-13T04:45:53.225961+00:00","last_reviewed_on":"2026-09-13T04:45:53.225961+00:00","identity":{"legal_name":"Axogen, Inc.","display_name":"Axogen, Inc.","headline":"AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves.","description":"AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating t","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0000805928","logo":"https://cdn.brandfetch.io/ticker/axgn/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/axgn/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"Axogen, Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-13T04:45:53.225961+00:00"},"security_listings":[{"ticker":"AXGN","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"Axogen, Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Medical - Devices","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/axogen-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-13T04:45:53.225961+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":18,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":18,"corroborated_claims":0,"sources":3,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-13T04:45:53.225961+00:00","observed_at":"2026-09-13T04:45:53.225961+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"axogen-inc","canonical_url":"https://registry.alpha.ac/companies/axogen-inc"},"publication":{"published_at":"2026-09-13T04:45:53.225961+00:00","last_reviewed_at":"2026-09-13T04:45:53.225961+00:00","as_of":"2026-09-13T04:45:53.225961+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/axogen-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/axogen-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/axogen-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"axogen-inc","canonical_url":"https://registry.alpha.ac/companies/axogen-inc","as_of":"2026-09-13T04:45:53.225961+00:00","last_reviewed_at":"2026-09-13T04:45:53.225961+00:00","identity":{"legal_name":"Axogen, Inc.","display_name":"Axogen, Inc.","description":"AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating t","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Medical - Devices","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0000805928","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"AXGN","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"86f050f5-f12c-4af6-a1c1-4b0d870daae9","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-13","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"paul-thomas-axgn","display_name":"Paul Thomas","role_category":"director","title":"Chairman of the Board","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0000805928-26-000057","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_def_14a","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-06T01:07:26.250818+00:00"},"headshot_url":null},{"person_slug":"alan-m-levine-axgn","display_name":"Alan M. Levine","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.567993+00:00"},"headshot_url":null},{"person_slug":"amy-wendell-axgn","display_name":"Amy Wendell","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2016-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.567993+00:00"},"headshot_url":null},{"person_slug":"john-h-johnson-axgn","display_name":"John H. Johnson","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.567993+00:00"},"headshot_url":null},{"person_slug":"joseph-tyndall-axgn","display_name":"Joseph Tyndall","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.567993+00:00"},"headshot_url":null},{"person_slug":"kathy-weiler","display_name":"Kathy Weiler","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0000805928-26-000057","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_def_14a","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-06T01:07:26.250818+00:00"},"headshot_url":null},{"person_slug":"michael-dale-axgn","display_name":"Michael Dale","role_category":"director","title":"Director, Chief Executive Officer and President","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0000805928-26-000057","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_def_14a","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-06T01:07:26.250818+00:00"},"headshot_url":null},{"person_slug":"william-burke-axgn","display_name":"William Burke","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.567993+00:00"},"headshot_url":null}],"executives":[{"person_slug":"erick-devinney-axgn","display_name":"Erick DeVinney","role_category":"executive","title":"Chief Innovation Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.61952+00:00"},"headshot_url":null},{"person_slug":"jens-kemp-axgn","display_name":"Jens Kemp","role_category":"executive","title":"Chief Marketing Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A axgn-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:56:59.634475+00:00"},"headshot_url":null},{"person_slug":"lindsey-hartley","display_name":"Lindsey Hartley","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0000805928-26-000057","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_def_14a","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-06T01:07:26.250818+00:00"},"headshot_url":null},{"person_slug":"marc-began","display_name":"Marc Began","role_category":"executive","title":"Executive Vice President and General Counsel","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0000805928-26-000057","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_def_14a","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-06T01:07:26.250818+00:00"},"headshot_url":null},{"person_slug":"michael-dale-axgn","display_name":"Michael Dale","role_category":"executive","title":"Chief Executive Officer and President","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0000805928-26-000057","source_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000057/axgn-20260429.htm","source_type":"sec_def_14a","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-06T01:07:26.250818+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/axogen-inc#profile","url":"https://registry.alpha.ac/companies/axogen-inc","dateModified":"2026-09-13T04:45:53.225961+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/axogen-inc#organization","legalName":"Axogen, Inc.","name":"Axogen, Inc.","description":"AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating t","url":"https://registry.alpha.ac/companies/axogen-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Chairman of the Board","member":{"@type":"Person","name":"Paul Thomas","url":"https://registry.alpha.ac/people/paul-thomas-axgn"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Alan M. Levine","url":"https://registry.alpha.ac/people/alan-m-levine-axgn"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2016-01-01","member":{"@type":"Person","name":"Amy Wendell","url":"https://registry.alpha.ac/people/amy-wendell-axgn"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"John H. Johnson","url":"https://registry.alpha.ac/people/john-h-johnson-axgn"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Joseph Tyndall","url":"https://registry.alpha.ac/people/joseph-tyndall-axgn"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Kathy Weiler","url":"https://registry.alpha.ac/people/kathy-weiler"}},{"@type":"OrganizationRole","roleName":"Director, Chief Executive Officer and President","member":{"@type":"Person","name":"Michael Dale","url":"https://registry.alpha.ac/people/michael-dale-axgn"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"William Burke","url":"https://registry.alpha.ac/people/william-burke-axgn"}},{"@type":"OrganizationRole","roleName":"Chief Innovation Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Erick DeVinney","url":"https://registry.alpha.ac/people/erick-devinney-axgn"}},{"@type":"OrganizationRole","roleName":"Chief Marketing Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Jens Kemp","url":"https://registry.alpha.ac/people/jens-kemp-axgn"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","member":{"@type":"Person","name":"Lindsey Hartley","url":"https://registry.alpha.ac/people/lindsey-hartley"}},{"@type":"OrganizationRole","roleName":"Executive Vice President and General Counsel","member":{"@type":"Person","name":"Marc Began","url":"https://registry.alpha.ac/people/marc-began"}},{"@type":"OrganizationRole","roleName":"Chief Executive Officer and President","member":{"@type":"Person","name":"Michael Dale","url":"https://registry.alpha.ac/people/michael-dale-axgn"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/axogen-inc"}},"canonical_source":"aegis_canonical"}